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Abstract  
 
Background 
The association between atopic dermatitis (AD) and food allergy (FA) is not fully 
understood, although a causal relationship has been suggested. This has important 
implications for prevention and treatment.  
Objective 
We aimed to review associations between AD and FA; the impact of FA on AD 
severity, chronicity, age of onset and the temporal relationship between the two.  
Methods 
Medline and Embase were systematically searched from inception to November 
2014 for studies investigating both AD and FA.  
Results 
66 studies were identified. 18 were population-based, 8 utilized high-risk cohorts, 
and the rest comprised patients with either established AD or FA. In population-
based studies, the likelihood of food sensitization was <6 times higher in AD patients 
versus healthy controls at 3 months of age (OR=6.18, 95% CI 2.94-12.98, p<0.001). 
Other population-based studies reported the prevalence of food sensitization in AD 
patients as <53%, and <15% for challenge-proven FA. Meanwhile, studies including 
only patients with established AD have reported the prevalence of food sensitization 
as <66%, and <81% for challenge-proven FA. 16 studies suggested that FA is 
associated with a more severe AD phenotype. 6 studies indicated that AD of earlier 
onset or increased persistence is particularly associated with FA. Finally, one study 
found that AD preceded the development of FA.  
Conclusions 
This systematic review confirms a strong and dose-dependent association between 
AD, food sensitization and FA. AD of increased severity and chronicity is particularly 
associated with FA. There is also evidence that AD precedes the development of 
food sensitization and allergy, in keeping with a causal relationship.  
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Key Messages  
• There is a strong association between AD, food sensitization and FA 
• AD of increased severity and chronicity is particularly associated with FA 
• AD arises before the development of food sensitization in most cases, 
supporting a causal relationship 
 
Capsule Summary  
This systematic review suggests a strong association between AD and FA. AD of 
increased severity and chronicity appears to be particularly associated with FA. 
Finally, AD may arise before the development of food sensitization, supporting a 
causal relationship. 
 
Abbreviations 
AD – atopic dermatitis 
aOR – adjusted odds ratio 
DBPCFC – double blind placebo controlled food challenge 
FA – food allergy 
FLG – filaggrin gene 
fx1 – mixed sensitization to peanut, hazelnut, brazil nut, almond & coconut 
fx5 – mixed sensitization to milk, egg, wheat, soy, cod & peanut 
kU/L – kilounits per litre 
OFC – open food challenge 
OR – odds ratio 
PPV – positive predictive value 
SD – standard deviation 
SCORAD – SCORing Atopic Dermatitis  
sIgE – specific IgE 
SPT – skin prick test 
  
Introduction 1 
Atopic dermatitis (AD, syn. ‘atopic eczema’, ‘childhood eczema’) is the commonest 2 
chronic inflammatory disorder of the skin, affecting over 20% of children in 3 
industrialized countries (1-3) and up to 3% of adults (4). Although up to two thirds of 4 
patients with AD do not show sensitization to environmental allergens, including 5 
foods (5), AD is often associated with other atopic diseases such as IgE-mediated 6 
food allergy (FA) (6), and around one third of all children with early onset AD 7 
progress through the so-called ‘atopic march’ (7). It has been suggested that food 8 
allergen recognition via antigen-presenting cells in eczematous skin may act as an 9 
important mediator of food sensitization and FA (8,9). To further assess a potential 10 
causal pathway between AD and IgE-mediated FA, this systematic review critically 11 
appraises the current body of evidence according to the Bradford Hill (10) principles 12 
of inferring causality from clinical studies. These principles take into account i) the 13 
strength of the association between AD and FA in selected and unselected 14 
populations, ii) whether a dose-response effect is demonstrated, with more severe 15 
AD showing a greater association with FA, and equally whether FA may predict age 16 
of onset or chronicity of AD, as well as iii) the temporal sequence of events - in other 17 
words, whether AD or FA arises first amongst infants. 18 
 19 
 20 
 21 
 22 
  23 
Methods 24 
 25 
This systematic review was registered on PROSPERO (11), and PRISMA guidance (12) 26 
was followed throughout. Medline and Embase were searched from inception to the 27 
end of November 2014, with no language limits imposed. Search terms included the 28 
Cochrane Skin Group strategy for AD, combined with terms describing FA, food 29 
hypersensitivity and food sensitization overall, as well as to specific foods (including 30 
milk, egg, peanut, tree nuts, wheat, sesame and seafood). The full search strategy is 31 
available in the Online Repository. This online search was supplemented by an 32 
extensive hand search of the literature, and communication with individual authors 33 
where necessary. The Medline search identified 339 articles, the Embase search 34 
1,704 articles, and the hand search a further 34 articles (Figure 1 Online Repository).  35 
Two authors (TT and MM) independently screened all abstracts for suitability, 36 
resulting in 164 papers that were read in full. Discrepancies in the assessment were 37 
resolved through discussion with CF. Paper selection for further analysis was based 38 
upon the following inclusion criteria: 1. The majority of subjects comprising patients 39 
<18 years of age 2. At least a proportion of subjects having AD and an overlapping 40 
proportion of subjects having food sensitization and/or FA, evidenced by at least one 41 
of skin prick testing (SPT, standard cutoff 3mm wheal), serum specific IgE (sIgE, 42 
standard cutoff 0.35 kU/L), open food challenge (OFC), or double-blind placebo-43 
controlled food challenge (DBPCFC). Exclusion criteria were: 1. AD diagnostic criteria 44 
including SPT/sIgE sensitization to common allergens, as well as typical skin findings 45 
2. FA evidenced only by parent or patient-reported symptoms 3. Data referring to 46 
mixed food and aeroallergen sensitization, with no separate values provided for food 47 
allergens. Furthermore, we excluded management guidance documents, reviews, 48 
intervention trials and studies in animal models. 49 
Data was extracted from 66 selected papers using a predefined pro forma. Formal 50 
meta-analysis was considered neither feasible nor appropriate due to marked 51 
heterogeneity in study design, participants, and diagnostic criteria for both FA and 52 
AD. We therefore assigned a quality score to each paper (maximum score three 53 
points) based on: AD diagnostic criteria (1: clear validated criteria or physician 54 
diagnosis, 0: unclear diagnostic criteria or process); study size (1: >500 subjects, 0: 55 
<500 subjects); and a modified Newcastle-Ottawa score (13) (1: >4 out of 5 points, 0: 56 
<4 points). Papers were then ranked by quality score. Those with the same quality 57 
score were further ranked by number of participants. 58 
 59 
 60 
 61 
 62 
 63 
 64 
 65 
 66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
 74 
 75 
  76 
Results 77 
 78 
The strength of association between AD and FA  79 
Population-based studies (Table I Online Repository) 80 
Eleven population-based studies scored three points for quality, and their results 81 
closely reflect the age groups of the children they investigated (Figure 2).  82 
The largest study (14) utilized a case-control design nested within the consecutively 83 
recruited BAMSE birth cohort (n=2256), reporting that 27% of AD cases at 2 years 84 
were SPT positive to food (egg 21%, peanut 15%, milk 8%, cod 2%). The second-85 
largest study (15) investigated SPT sensitization amongst much older children aged 86 
12-16 years, who were participating in the Danish Adolescent Odense Cohort (TOACS, 87 
n=1501). Whilst a strongly positive association was demonstrated between current 88 
AD and peanut sensitization (16.2% of AD patients vs. 0.5% of controls, p<0.05) 89 
during adolescence, no significant differences persisted for milk and egg sensitization. 90 
Investigations amongst younger children reflected the higher prevalence of milk and 91 
egg allergies within that age group (Figure 2).  92 
Two high quality population-based papers were based on the Isle of Wight allergy 93 
birth cohort (n=1456), with Arshad et al. (16) reporting that at 4 years of age, the 94 
highest independent risk factor for AD was SPT sensitization to peanut (OR 4.65, 95% 95 
CI 1.02-21.34). There was also a positive association with egg sensitization; this just 96 
missed statistical significance (OR 6.08, 95% CI 0.88-42.01), likely due to a lack of 97 
power whilst a proportion of children were outgrowing their egg allergy.  98 
Meanwhile, Peroni et al.’s cross-sectional study (17) of 1,402 UK children aged 3-5 99 
years found that egg sensitization on SPT was strongly associated with AD (OR 9.53, 100 
95% CI 2.40-37.82), whilst milk sensitivity was not (OR 1.26, 95% CI 0.27-6.00). 101 
The Danish Allergy Research Cohort (DARC) (18) monitored babies from the age of 3 102 
months to 6 years, undertaking food challenges in children with food-specific SPT 103 
>3mm/sIgE >class 1, and also in children with parent-reported adverse reactions to 104 
food. The investigators reported that 18/122 (15%) of children with AD 105 
demonstrated symptoms on food challenge, and that 52% of the remainder were 106 
food sensitized. More recently, Flohr et al. analyzed those undergoing SPT at 3 107 
months within the EAT Study UK birth cohort (n=619) (9), reporting that children 108 
with AD were significantly more likely than healthy controls to be sensitized to at 109 
least one of six foods (milk, egg, sesame, peanut, wheat or cod), with an adjusted OR 110 
(aOR) of 8.53 (95% CI 3.51-20.65, p<0.001). This association was independent of 111 
filaggrin (FLG) loss-of-function mutation inheritance. Equally, there was a positive 112 
association between AD and sensitization to individual foods, including egg (aOR 113 
9.48, 95% CI 3.77-23.83, p<0.001), milk (aOR 9.11, 95% CI 2.27-36.59, p=0.002), and 114 
peanut (aOR 4.09, 95% CI 1.00-13.16.76, p=0.05).  115 
In Figures 3-5, ORs for each of the major food allergens are presented in order of 116 
ascending age of participants at cross-sectional analysis. Pooling of results between 117 
allergens and beyond the first six years of childhood was not considered appropriate 118 
in view of the contrasting natural history of individual allergens, as well as the 119 
changes in association seen for each individual food allergen as a child becomes 120 
older.  121 
High-risk cohort studies (Table II Online Repository) 122 
Eight papers were based on high-risk cohorts, recruiting according to parental atopy. 123 
Burr et al.’s UK study (n=497) (19) reported a significant association between AD 124 
arising before the first birthday and positive SPT to egg at 6 months (OR 5.57, 95% CI 125 
2.70-11.5); this was even stronger at 1 year (OR 7.57, 95% CI 3.57-16.05) (20).  126 
Three papers utilized the Melbourne Atopy Cohort Study cohort (MACS, n=552), 127 
including Lowe et al.’s report (21) that food SPT sensitization at 6 months was 128 
associated with an increased risk of developing AD (HR 1.63, 95% CI 1.13–2.35) up to 129 
7 years of age. This was in line with other MACS data from Hill et al. (22), who found 130 
that more AD patients had positive SPT to milk, egg, or peanut at 6 months (22% vs. 131 
5%, p<0.001) and at 12 months (36% vs. 11%, p<0.001) than those without AD 132 
(Figure 6 Online Repository). Four years later, the same group reported that 36% of 133 
infants with AD had positive food SPT, compared with 12% of infants without AD 134 
(p<0.001) (23). Recently, Brough et al. (24) investigated whether AD and disease 135 
severity modified the strength of the association between environmental peanut 136 
protein exposure and the risk of peanut sensitization and peanut allergy. 512 137 
American infants (<15 months old) with egg/milk SPT sensitization plus either 138 
parent-reported egg/milk allergy or parent-reported AD, were recruited from the 139 
Consortium of Food Allergy Research study (CoFAR, n=512). Environmental peanut 140 
exposure was quantified from dust on the living room floor. An association between 141 
environmental peanut exposure and the likelihood of peanut sensitization or allergy 142 
was only seen in participants with a history of AD. Indeed, history of AD and 143 
increased environmental peanut exposure in participants was found to increase the 144 
risk of both peanut sensitization (OR 1.97, 95% CI 1.26-3.09, p<0.01) and peanut 145 
allergy (OR 2.34, 95% CI 1.31-4.18) per log2 unit environmental peanut exposure 146 
increase. The effect for peanut sensitization was further augmented with a history of 147 
severe AD (OR 2.41, 95% CI 1.30-4.47, p<0.01), although this was not observed for 148 
peanut allergy.  149 
Studies investigating FA and food sensitization amongst children with established AD 150 
(Table III Online Repository) 151 
Thirty-four studies selected groups of patients with established AD rather than 152 
taking a population-based approach, and therefore are likely to have inflated 153 
prevalence estimates of atopy. Two investigations (25,26) comprising >2,000 154 
subjects aged 11.8-25.8 months from 12 countries were derived from the Early 155 
Prevention of Asthma in the Atopic Child (EPAAC) study cohort. Hill et al. (25) 156 
reported that 64% of those with AD commencing before 3 months of age were 157 
sensitized to egg and/or milk and/or peanut, based on sIgE >95% PPV. The following 158 
year, De Benedictis et al. (26) compared the allergic sensitization patterns associated 159 
with AD between the 12 countries, reporting that positive sIgE to egg predominated 160 
in each country (53% in the UK), whereas milk sensitization was highest in Italy (48%) 161 
and peanut sensitization was highest in Australia (45%). 162 
Of note, 16 studies in patients with established AD reported oral food challenge data 163 
as well as sensitization data. However, many failed to apply systematic criteria in 164 
determining who was eligible for food challenges, limiting their insight. One of the 165 
largest studies (27) in this category was performed in Finland, and reported a 166 
prevalence of 54% for milk allergy amongst 183 children with AD up to 3 years old.  167 
Burks et al. (28) proposed a standard food SPT panel for AD patients recruited from a 168 
paediatric allergy clinic in the USA. This group reported that out of 165 participants 169 
aged between 4 months and 22 years, 60% had at least one positive SPT response. 170 
The investigators then performed 266 DBPCFCs, and 39% of patients reacted to 171 
seven foods (milk, egg, peanut, soy, wheat, cod/catfish, cashew), accounting for 89% 172 
of the positive challenges.  173 
Finally, Gray et al. (29) investigated 100 black or mixed race children who attended 174 
an urban Cape Town clinic with moderate to severe AD. The authors reported high 175 
rates of food sensitization (66%) and challenge-confirmed FA (44%), with egg and 176 
peanut being the most common allergens.  177 
Studies investigating AD amongst children with established FA (Table IV Online 178 
Repository) 179 
Four investigations selected patients with established FA, then measured the 180 
prevalence of AD. Two of these were particularly enlightening, and both focused on 181 
children with peanut allergy.  182 
Fox et al. (30) compared 133 patients with peanut allergy, 160 high-risk controls with 183 
allergy to egg but not peanut, and 150 low-risk controls with no known allergy. Cases 184 
and high-risk controls were recruited from food allergy clinic, whereas low-risk 185 
controls were recruited from children attending general paediatric clinic with a non-186 
allergic complaint. A parent-reported history of AD in the first year of life was highly 187 
prevalent amongst both cases (92%) and high-risk controls (88%), but significantly 188 
less so amongst low-risk controls (42%; p<0.001).  189 
More recently, Brown et al. (8) investigated the role of FLG mutations as a risk factor 190 
for peanut allergy. The study design comprised 71 patients aged up to 18 years from 191 
the UK, Ireland and the Netherlands with challenge-proven peanut allergy, and 1000 192 
non-peanut sensitized population controls. Covariate analysis using both AD and FLG 193 
as predictors in the logistic regression model demonstrated a strong association 194 
between AD and peanut allergy in challenge-positive patients, with an OR of 7.4 195 
(95% CI 4.1-13.7). The association between FLG mutation inheritance and peanut 196 
allergy remained significant, even after adjustment for a history of AD in early life 197 
(OR 3.8, 95% CI 1.7-8.3, p<0.001). 198 
 199 
The association between AD severity and FA 200 
22 papers addressed the question of whether FA impacts on AD severity. Flohr et 201 
al.’s UK population-based study (9) amongst 619 exclusively breastfed 3 month old 202 
infants was the highest quality paper in this area, showing that the association 203 
between AD and sensitization to milk, raw egg, cod, sesame, and peanut was 204 
significantly stronger in AD with SCORAD >20 (aOR 25.60, 95% CI 9.03-72.57, 205 
p<0.001) than AD with SCORAD <20 (aOR 3.91, 95% CI 1.70-9.00, p=0.001).  206 
Four papers were awarded 2 quality points; for instance, Lack et al.’s case control 207 
study (31) found a trend towards an association between the severity of a flexural 208 
rash (as determined by topical steroid usage) in the first 6 months, and a history of 209 
peanut allergy and a positive peanut challenge (p<0.001 for both associations). 210 
When the same research group performed screening assessments amongst 834 211 
infants, in order to enroll those with egg allergy and/or severe eczema into the 212 
Learning Early About Peanut (LEAP) trial, a strong association between food 213 
sensitization and AD severity was evident (32). When the infants were split into 214 
three SCORAD severity groups, increasing AD severity was associated with a higher 215 
likelihood of sensitization to peanut (ptrend<0.001), raw egg (ptrend<0.001), 216 
pasteurized egg (ptrend<0.001), milk (ptrend=0.001) and ‘any food’ (ptrend<0.001).  217 
In a group of Australian infants whose AD did not respond to topical steroid therapy, 218 
the equivalent rates of SPT food sensitization were 83% at 6 months and 65% at 12 219 
months. The relative risk estimates for SPT food sensitization also rose with 220 
increasing AD severity as defined by topical steroid use in the first year of life (23).  221 
In a later study by the same group, based on the EPAAC cohort of 2084 infants with 222 
AD, the authors used regression analysis to show that children with sIgE to milk, egg 223 
or peanut >95% PPV were more likely to have severe eczema of early onset up to 224 
one year of age (p<0.001) (25). Lastly, data from the South African paediatric cohort 225 
(n=100) (29) showed that 15/50 (30%) children with moderate AD were food allergic, 226 
compared to 25/50 (50%) in those with severe AD (p=0.04).  227 
 228 
Is FA associated with earlier onset of AD and greater chronicity?  229 
Six papers examined whether FA is associated with AD of early onset or increased 230 
chronicity, including Hill et al.’s 2008 paper as mentioned above (25). The best 231 
quality study (33) assessed the relationship between FLG status, AD, food 232 
sensitization and FA (inferred from symptom-based diagnosis) in patients up to 18 233 
years of age on the Isle of Wight (n=1456). AD at 1 and 2 years of age was associated 234 
with both FA (OR 6.04, 95% CI 1.25-29.9, p<0.001) and food sensitization (OR 20.1, 235 
95% CI 4.40-54.50, p<0.001) at 4 years, and sensitization at 18 years (OR 18.2, 95% CI 236 
5.47-65.3, p<0.001). In addition, AD at 4 years was linked to food sensitization at 10 237 
years (OR 6.9, 95% CI 3.65-13.04, p<0.001) and 18 years (OR 3.82, 95% CI 2.44-5.99, 238 
p<0.001), suggesting longer-term FA sequelae.  239 
Supportive papers in this area include Ricci et al.’s retrospective analysis (34) of 252 240 
infants with AD, in which egg sensitization was associated with more prolonged AD 241 
(egg sensitized: mean 11.1 +6.9 years vs. non egg-sensitized: 8.3 +6.9 years, p<0.02). 242 
As described above, Fox et al.’s case control study (30) examining peanut allergy 243 
showed that parent-reported AD in the first year of life was significantly less 244 
prevalent amongst low-risk controls recruited from general as opposed to food 245 
allergy clinics; furthermore, AD in low-risk controls was significantly later in onset 246 
and also less severe (p<0.001).  247 
The Belgian ETAC cohort (n=397) (35) showed that egg and milk sIgE sensitization at 248 
enrolment was associated with persisting AD (SCORAD>7) at 18 months follow-up 249 
(p=0.006). Burks et al. (28) showed that children with both positive SPTs and 250 
DBPCFCs had a significantly lower age of AD onset than patients without (2 months 251 
vs. 7 months, p=0.003). Finally, Gray et al.’s South African study (29) reported that 252 
onset of AD before 6 months was a significant risk factor for FA (p=0.002). 253 
 254 
Is there a temporal relationship between the development of AD and FA?  255 
Two papers (18,33) repeatedly examined for AD and food sensitization throughout 256 
childhood, and one of these (18) initiated this early enough to discriminate between 257 
the emergence of AD and FA. 562 participants were recruited at birth in the Danish 258 
general population, and were followed up at 3, 6, 9, 12, 18, 36 and 72 months of age. 259 
All follow-ups except the 9-month visit included an interview, clinical examination, 260 
and SPT/sIgE measurements. Where food related symptoms were declared, OFCs 261 
were undertaken. By three months of age, 2% of the cohort was found to have signs 262 
of AD on examination, and yet none of the participants demonstrated symptoms on 263 
OFC at that age (Figure 7).  264 
Unfortunately, the Isle of Wight cohort (33) only investigated food sensitization 265 
amongst children whose families reported adverse food reactions before 4 years of 266 
age, preventing a population-based comparison. 267 
Of note, Soderstrom et al.’s high-risk birth cohort study (36) was unique in that it 268 
focused solely on low levels of sIgE, in an attempt to capture allergic sensitization at 269 
the earliest possible stage. All IgE levels exceeding 0.7 kUA/l were therefore omitted 270 
in the risk analysis. AD at 2 years of age was associated with increased low-level 271 
sensitization to egg and/or milk at 6 months (OR 3.07, 95% CI 1.44-6.55), 12 months 272 
(OR 3.33, 95% CI 1.60-6.96) and 24 months (OR 1.74, 95% CI 1.01-3.01). However, 273 
35% of 6 month old infants already had AD and were not excluded from the analysis, 274 
meaning that low-grade sensitization may relate more to the persistence of AD that 275 
is already established, as opposed to newly arising AD. Furthermore, no follow-up 276 
data on clinical FA status was reported.  277 
Four papers investigated cord blood sIgE, attempting to assess the possibility that 278 
food sensitization precedes the development of AD. The ALSPAC cohort study (31) 279 
followed children until they developed challenge-proven peanut allergy, but found 280 
no relationship with cord blood peanut sIgE levels. Likewise in the DARC cohort (37), 281 
food sIgE proved no better than total cord IgE in predicting AD within the first 18 282 
months of life. Overall, the key message from these studies is that cord blood sIgE is 283 
rarely detectable and not a significant risk factor, in line with the hypothesis that AD 284 
precedes and is likely to drive food sensitization. 285 
 286 
 287 
  288 
Discussion 289 
This review interrogates whether AD causes FA according to the established 290 
Bradford Hill principles (10). We found a significant association between FA, food 291 
sensitization and AD in both selected and unselected populations. FA is associated 292 
with AD of increased severity and chronicity. In addition, there is tentative evidence 293 
from one study suggesting that AD may arise before FA. 294 
Our systematic review protocol was registered online in advance, in keeping with 295 
PRISMA guidelines (12). Cognizant of the potential for bias in literature searching, we 296 
supplemented the online search strategy with an extensive hand search to maximize 297 
capture of relevant publications. However, this would not overcome inherent 298 
limitations such as publication bias. 66 publications fulfilled our selection criteria, of 299 
which 12 scored 3 out of 3 in our a priori independent quality grading. The 66 300 
selected papers represent 3% of the total number of articles identified via our online 301 
search and hand search. Amongst these, substantial methodological differences and 302 
study heterogeneity (different age groups, sIgE/SPT cutoffs, and food challenge 303 
protocols) precluded formal meta-analysis. Only 49/66 (74%) studies stated the use 304 
of doctor diagnosis and/or validated diagnostic criteria for AD, and only 26/66 (39%) 305 
studies used food challenges to determine FA status. Furthermore, the rationale for 306 
investigating certain subgroups of participants was often unclear, with numerous 307 
studies employing food challenges only in selected patients. Where food 308 
sensitization was investigated, only four papers used values equating to the 95% PPV 309 
cutoff as part of their methodology for diagnosing food allergy (see summary of 310 
study limitations, Table V Online Repository).  311 
It is a challenge for any study to capture the emergence of both AD and FA, partly 312 
because AD characteristically waxes and wanes. In addition, clinical FA, in particular 313 
to egg and peanut, often arises without the child having ever specifically ingested 314 
the food in question. Therefore, the only way of investigating the emergence of FA is 315 
to prospectively screen for food sensitization at regular intervals, and perform OFCs 316 
throughout infancy. Given the strong association found between early onset, and 317 
also moderate-to-severe AD and food sensitization, as well as the low content of 318 
food allergens in breast milk and lack of sIgE in cord blood, it is likely that food 319 
sensitization occurs across the inflamed skin barrier in eczematous skin, potentially 320 
leading to the development of clinical FA. Brough et al. have recently shown that 321 
food protein content in dust samples collected from the infant’s environment, such 322 
as the living room floor, predisposes towards early food sensitization, especially in 323 
the presence of eczematous skin inflammation (24). Indeed, carrying a FLG mutation 324 
additionally raised this risk, further supporting the evidence that a disrupted skin 325 
barrier predisposes towards sensitization. However, detailed work from our own 326 
birth cohort demonstrated that it is the presence of AD and its severity, rather than 327 
FLG mutation carriage per se, that relates to food sensitization risk in early life (9).  328 
When investigating the role of food allergen ingestion as a prevention strategy, the 329 
interplay between environmental versus oral food allergen exposure alongside AD 330 
status and management becomes of crucial importance. Fallon et al. used the FLG-331 
deficient flaky tail mouse model to demonstrate that the application of ovalbumin to 332 
intact yet FLG-deficient mouse skin was sufficient to induce cutaneous inflammation 333 
and increase ovalbumin sIgE (38). Bartnikas et al. (39) contrasted the physiological 334 
effect of epicutaneous sensitization with that of oral tolerance induction.  BALB/c 335 
mice were epicutaneously sensitized with repeated applications of ovalbumin to 336 
tape-stripped skin over 7 weeks, or orally immunized with ovalbumin and cholera 337 
toxin over 8 weeks. Both the epicutaneous and orally exposed groups of mice 338 
demonstrated specific IgE antibody responses, and yet only those without oral 339 
immunization developed signs in keeping with anaphylaxis on oral challenge. Thus 340 
the determination of food allergy or tolerance depends not only upon a period of 341 
cutaneous sensitization, but also the timing and likely dose of GI tract allergen 342 
exposure. 343 
The design of methodologically sound studies examining the dynamic and 344 
interrelated nature of AD and FA will facilitate the generation of future therapeutic 345 
and preventative interventions (Table V Online Repository). Recent data in humans 346 
has shown that carrying a FLG mutation disrupts the infant skin barrier by 3 months 347 
of age, even before AD emerges (40). Two small intervention studies (41,42) suggest 348 
that the regular application of emollients from birth reduces the risk of AD 349 
development and may thus impact upon FA, although the study investigating egg 350 
sensitization did not find a significant reduction (41).  351 
Finally, it is important to remember that FA can develop in patients without a prior 352 
diagnosis of AD. Lack et al.’s seminal paper showed that 5/8824 (0.06%) children 353 
without a history of a rash over joints or skin creases were peanut-allergic on 354 
DBPCFC (31). However, even in the absence of AD, skin barrier alterations of a 355 
different nature may play a role in the development of FA. For instance, Flohr et al.’s 356 
previously discussed study also found an independent positive association between 357 
skin barrier impairment (raised TEWL) and food sensitization, even in the absence of 358 
clinically visible skin inflammation (9). Other environmental factors, such as water 359 
hardness, the use of soaps and detergents and the frequency of washing, could 360 
further contribute to skin barrier permeability and thus food sensitization (1). These 361 
are all areas that warrant further research.  362 
The evidence presented in this systematic review provides further support for skin 363 
barrier repair, early proactive AD treatment, and reduction of environmental food 364 
allergen exposure in the prevention of food sensitization and allergy. Large 365 
population-based intervention studies, using validated diagnostic criteria and gold 366 
standard food challenges, are required to test this hypothesis further. 367 
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